References
- Allam G, Nasr A, Talaat IM, et al. (2017). Association between cytokine genes polymorphisms and type 1 diabetes: a case-control study on Saudi population. Immunol Invest. 47, 229–240. doi:10.1080/08820139.2017.1416398.
- Amarapurpar DN, Patel ND, Kankonkar SR. (2003). HLA class II genotyping in chronic hepatitis B infection. J Assoc Physicians India. 51, 779–781.
- Bhimma R, Hammond MG, Coovadia HM, et al. (2002). HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy. Kidney Int. 61, 1510–1515. doi:10.1046/j.1523-1755.2002.00287.x.
- Clayton J, Gee H. (1993). Major histocompatibility complex: the evolutionary angle. Nature. 365, 111–112. doi:10.1038/365111a0.
- Constantinescu I, Boscaiu V, Moise A. (2017). HLA allele distribution in Romanian people: clinical significance and utility related to population genetic background. Immunogenetics. 2, 115.
- Corrêa BD, Lopes EP, Albuquerque MD, et al. (2012). Association between HLA-DRB1* polymorphisms and hepatitis B infection in a Brazilian population. Rev Assoc Med Bras, 58, 537–542.
- Czaja AJ, Doherty DG, Donaldson PT. (2002). Genetic bases of autoimmune hepatitis. Dig Dis Sci. 47, 2139–2150.
- Ganem D, Prince AM. (2004). Hepatitis B virus infection – natural history and clinical consequences. New Engl J Med. 350, 1118–1129. doi:10.1056/NEJMra031087.
- Hohler T, Gerken G, Notghi A, et al. (1997). HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol, 26, 503–507.
- Klein J, Sato A. (2000). The HLA system: first of two parts. N Engl J Med. 343, 702–709. doi:10.1056/NEJM200009073431006.
- Lavanchy D. (2004). Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures. J Viral Hepat, 11, 97–107. doi:10.1046/j.1365-2893.2003.00487.x.
- Lok AS, McMahon BJ. (2007). Chronic hepatitis B. Hepatology. 45, 507–539. doi:10.1002/hep.21513.
- Martin MP, Carrington M. (2005). Immunogenetics of viral infections. Curr Opin Immunol. 17, 510–516. doi:10.1016/j.coi.2005.07.012.
- McCanlies EC, Kreiss K, Andrew M, Weston A. (2003). HLA-DPB1 and chronic beryllium disease: a huge review. Am J Epidemiol. 157, 388–398. doi:10.1093/aje/kwg001.
- Mohammadi M, Farazmandfar T, Shahbazi M. (2017). Relationship between human leukocyte antigen (HLA)-DQA1*0102/HLA-DQB1*0602 polymorphism and preeclampsia. Int J Reprod Biomed, 15, 569–574. doi:10.29252/ijrm.15.9.569.
- Moradpour D, Blum HE. (2002). Hepatitis B carrier: definition and diagnosis. In: Sarin SK, ed. Hepatitis B and C – Carrier to Cancer. first. Delhi: Harcourt India Private Limited, 3–8.
- Mosaad YM, El-Toraby EE, Tawhid ZME, et al. (2018). Association between CD226 polymorphism and soluble levels in rheumatoid arthritis: relationship with clinical activity. Immunol Invest. 47, 264–278. doi:10.1080/08820139.2018.1423570.
- National Center for Communicable Disease Surveillance and Control. (2014a). http://www.cnscbt.ro/index.php/analiza-date-supraveghere/hepatita-virala-tip-b-si-c/189-hepatita-virala-tip-b-si-c-anul-2014-analiza/file. Accessed 23 April 2018
- National Center for Communicable Disease Surveillance and Control. (2014b). https://www.cnscbt.ro/index.php/analiza-date-supraveghere/hepatita-virala-tip-b-si-c/405-rezultatele-studiului-epidemiologic-de-prevalenta-pentru-infectia-cu-virus-hepatitic-b-si-c-romania-anul-2013/file. Accessed 23 April 2018.
- National Institute of Statistics. (2011). http://www.recensamantromania.ro/rezultate-2/. Accessed 18 April 2018.
- Png E, Thalamuthu A, Ong RT, et al. (2011). A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum Mol Genet. 20, 3893–3898. doi:10.1093/hmg/ddr302.
- Purcell RH. (1993). The discovery of the hepatitis viruses. Gastroenterology, 104, 955–963. doi:10.1016/0016-5085(93)90261-A.
- Rashmi S, Rashmi K, Anil K, et al. (2007). A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroentero, 13, 1770–1787. doi:10.3748/wjg.v13.i12.1770.
- Seeger C, Mason WS. (2000). Hepatitis B virus biology. Microbiol Mol Biol Rev, 64, 51–68. doi:10.1128/MMBR.64.1.51-68.2000.
- Thio CL, Carrington M, O’Brien SJ, et al. (1999). Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis. 179, 1004–1006. doi:10.1086/314684.
- Thio CL, Thomas DL, Carrington M. (2000). Chronic viral hepatitis and the human genome. Hepatology, 31, 819–827. doi:10.1053/he.2000.4316.
- Thio CL, Thomas DL, Karacki P, et al. (2003). Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol, 77, 12083–12087.
- Thursz MR, Kwiatkowsli D, Allsopp CEM, et al. (1995). Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med. 332, 1065–1069. doi:10.1056/NEJM199504203321604.
- Thyagrajan SP, Jayaram S, Hari R, et al. (2002). Epidemiology of hepatitis B in India – a comprehensive analysis. In: Sarin SK, ed. Hepatitis B and C – Carrier to Cancer. first. Delhi: Harcourt India Private Limited, 25–39.
- Vermehren J, Lötsch J, Susser S, et al. (2012). A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers. PLoS One. 7, e32605. doi:10.1371/journal.pone.0032605.
- Wong DKH, Watanabe T, Tanaka Y, et al. (2013). Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One. 8, e66920. doi:10.1371/journal.pone.0066920.
- World Health Organization. (2017). Hepatitis B. http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed 14 July 2017.
- Xingku L, Wei L, Hongyan W, et al. (2012). The influence of HLA alleles and HBV subgenotypes on the outcomes of HBV infections in Northeast China. Virus Res. 163, 328–333. doi:10.1016/j.virusres.2011.10.020.
- Yang P-M, Sung JL, Chen DS. (1989). HLA-A, B, C and DR antigens in chronic hepatitis B viral infection. Hepato-Gastroenterol. 36, 363–366.
- Zavaglia C, Bortolon C, Ferrioli G, et al. (1996). HLA typing in chronic type B, D and C hepatitis. J Hepatol, 24, 658–665.